General Announcement for PLC

28/02/2022

MEMORANDUM OF UNDERSTANDING Sinaran Advance Group Berhad ("SAG" or the "Company") - Quarterly Update on Memorandum of Understanding ("MoU") entered into between Kanger International Berhad ("KIB") and K Star Healthcare Sdn. Bhd. (" K Star Healthcare"), a wholly-owned subsidiary of the Company ("the Parties") in relation to the Appointment of K Star Healthcare as the Sale Agent for Covid-19 vaccines in Malaysia

SINARAN ADVANCE GROUP BERHAD

Type Announcement
Subject MEMORANDUM OF UNDERSTANDING
Description 
Sinaran Advance Group Berhad ("SAG" or the "Company") - Quarterly Update on Memorandum of Understanding ("MoU") entered into between Kanger International Berhad ("KIB") and K Star Healthcare Sdn. Bhd. (" K Star Healthcare"), a wholly-owned subsidiary of the Company ("the Parties") in relation to the Appointment of K Star Healthcare as the Sale Agent for Covid-19 vaccines in Malaysia
 
Unless otherwise stated, all definitions and terms used in this announcement shall carry the same meanings as defined in the previous announcments made by the Company on the MoU on 26 October 2020, 28 October 2020, 11 November 2020, 20 November 2020, 25 February 2021, 10 March 2021, 21 May 2021, 30 September 2021 and 30 November 2021.

Reference is made to the annoucements pertaining to the MoU made between KIB and K Star Healthcare for the purpose of appointng K Star Healthcare as the sale agent of Covid-19 vaccines for the private clinics in Malaysia. 

Pursuant to Paragraph 9.29 of the Main Market Lisitng Requirement ("Main LR") of Burssa Securities, the Board of Directors of SAG wishes to inform that there is no material development pertaining to the MoU entered into between the Parties. 

Any material development will be announced to Bursa Securities in due course. 

This announcment is dated 28 February 2022.




Announcement Info

Company Name SINARAN ADVANCE GROUP BERHAD
Stock Name SINARAN
Date Announced 28 Feb 2022
Category General Announcement for PLC
Reference Number GA1-18022022-00027


Related Announcements for SINARAN
Date Title
18/05/2022 MEMORANDUM OF UNDERSTANDING Sinaran Advance Group Berhad ("SAG" or the "Company") - Termination on Memorandum of Understanding ("MoU") entered into between Kanger International Berhad ("KIB") and K Star Healthcare Sdn. Bhd. ("K Star Healthcare"), a wholly-owned subsidiary of the Company ("the Parties") in relation to the Appointment of K Star Healthcare as the Sale Agent for Covid-19 vaccines in Malaysia
25/04/2022 NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : BONUS ISSUES SINARAN ADVANCE GROUP BERHAD ("SAG" OR THE "COMPANY") BONUS ISSUE OF WARRANTS
22/04/2022 NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : BONUS ISSUES SINARAN ADVANCE GROUP BERHAD ("SAG" OR THE "COMPANY") BONUS ISSUE OF WARRANTS
21/03/2022 NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : FUND RAISING SINARAN ADVANCE GROUP BERHAD ("SAG" OR THE "COMPANY") BONUS ISSUE OF WARRANTS
11/02/2022 NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : ESOS SINARAN ADVANCE GROUP BERHAD ("SAG" OR THE "COMPANY") EMPLOYEES SHARE OPTION SCHEME ("ESOS")
11/02/2022 NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : FUND RAISING SINARAN ADVANCE GROUP BERHAD ("SAG" OR THE "COMPANY") BONUS ISSUE OF WARRANTS
28/01/2022 NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : BONUS ISSUES SINARAN ADVANCE GROUP BERHAD ("SAG" OR THE "COMPANY") BONUS ISSUE OF WARRANTS
14/01/2022 NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : FUND RAISING SINARAN ADVANCE GROUP BERHAD ("SAG" OR "COMPANY") PRIVATE PLACEMENT OF 30% OF THE ISSUED ORDINARY SHARES IN SAG
03/01/2022 NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : FUND RAISING SINARAN ADVANCE GROUP BERHAD ("SAG" OR THE "COMPANY") PRIVATE PLACEMENT OF UP TO 30% OF THE ISSUED ORDINARY SHARES IN SAG
30/11/2021 MEMORANDUM OF UNDERSTANDING Sinaran Advance Group Berhad ("SAG" or the "Company") Quarterly Update on Memorandum of Understanding ("MoU") entered into between Kanger International Berhad ("KIB") and K Star Healthcare Sdn. Bhd. ("K Star Healthcare") (the "Parties") in relation to the Appointment of K Star Healthcare, a wholly-owned subsidiary of SAG as the Sale Agent for Covid-19 vaccines in Malaysia